Guardant Health, Inc. (GH)
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and CDx versions) and GuardantOMNI. Complementing these diagnostic tools, Guardant Health also provides GuardantINFORM, an in-silico research platform leveraging an extensive clinical-genomic liquid biopsy dataset derived from advanced cancer patients. Innovation is a key focus, with the company currently developing the LUNAR-2 test, designed for the early detection of colorectal cancer in eligible asymptomatic individuals. Another emerging solution in development is GuardantConnect, an integrated software platform intended to link biopharmaceutical and clinical clients by connecting patients whose Guardant360 tests reveal actionable alterations with potentially relevant clinical trials. Furthermore, Guardant Health offers the Guardant Reveal Test, which aids in selecting neoadjuvant and adjuvant treatments for early-stage cancer patients. Its portfolio also includes a Guardant360 product for tissue genotyping and Guardant-19 for novel coronavirus detection. The company extends its expertise to biopharmaceutical companies and medical institutions through various development services, encompassing companion diagnostic development, regulatory approval support, clinical study management (including setup, monitoring, and maintenance), testing development, and kit fulfillment.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
Guardant Health, Inc.
No splits on record
Nothing in GH's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $982.02M | $739.02M | $563.95M | $449.54M | $373.65M | $286.73M | $214.38M | $90.64M | $49.84M | $25.25M |
| YoY Growth | 32.9% | 31.0% | 25.5% | 20.3% | 30.3% | 33.8% | 136.5% | 81.9% | 97.4% | - |
| Cost of Revenue | $349.01M | $289.8M | $227.05M | $156.32M | $122.91M | $92.53M | $70.72M | $43.21M | $31.62M | $22.12M |
| Gross Profit | $633.01M | $449.22M | $336.9M | $293.21M | $250.74M | $194.19M | $143.66M | $47.43M | $18.22M | $3.13M |
| Gross Margin | 64.5% | 60.8% | 59.7% | 65.2% | 67.1% | 67.7% | 67.0% | 52.3% | 36.6% | 12.4% |
| Research and Development | $364.19M | $347.75M | $367.19M | $373.81M | $263.22M | $149.86M | $86.29M | $50.71M | $25.56M | $10.86M |
| Selling, General, and Administrative | $706.07M | $545.06M | $451.03M | $463.78M | $398.52M | $299.28M | $139.73M | $89.66M | $69.27M | $36.11M |
| Other | $0 | $0 | $83.4M | $0 | $0 | $0 | $88K | $0 | $0 | -$1K |
| Total Operating Expenses | $1.07B | $892.81M | $901.62M | $837.59M | $661.74M | $449.14M | $226.03M | $140.37M | $94.84M | $46.97M |
| Operating Income (EBIT) | -$437.25M | -$443.59M | -$564.73M | -$544.38M | -$411M | -$254.95M | -$82.37M | -$92.94M | -$76.61M | -$43.85M |
| Operating Margin | -44.5% | -60.0% | -100.1% | -121.1% | -110.0% | -88.9% | -38.4% | -102.5% | -153.7% | -173.7% |
| Interest Expense | $3.9M | $2.58M | $2.58M | $2.58M | $2.58M | $4.77M | $1.18M | $1.25M | $2.7M | $3.02M |
| Interest Income | $34.09M | $53.69M | $35.37M | $6.07M | $3.93M | $10.17M | $13.74M | $5.27M | $2.23M | $733K |
| Other Income (Expense) | $19.71M | $8.51M | $85.96M | -$109.07M | $26.53M | $9.05M | $12.65M | $8.72M | -$6.6M | -$2.29M |
| Income Before Tax (EBT) | -$417.54M | -$435.09M | -$478.76M | -$653.45M | -$384.47M | -$245.9M | -$69.72M | -$84.22M | -$83.21M | -$46.13M |
| Income Tax Expense | -$1.26M | $1.28M | $685K | $1.14M | $300K | $379K | -$1.87M | $38K | $7K | $6K |
| Net Income | -$416.28M | -$436.37M | -$479.45M | -$654.59M | -$405.67M | -$253.78M | -$75.65M | -$85.06M | -$83.22M | -$46.14M |
| Net Income Margin | -42.4% | -59.0% | -85.0% | -145.6% | -108.6% | -88.5% | -35.3% | -93.8% | -167.0% | -182.7% |
| Supplementary Data | ||||||||||
| EPS | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.53 | -0.75 | -1.00 | -1.18 | -3.49 |
| Diluted EPS | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.53 | -0.75 | -1.00 | -1.18 | -3.49 |
| Weighted Average OS | 125.37M | 122.75M | 111.99M | 102.18M | 101.31M | 97.50M | 90.60M | 85.03M | 70.72M | 13.22M |
| EBITDA | -$373.91M | -$390.12M | -$433.31M | -$614.91M | -$359.62M | -$225.07M | -$57.13M | -$75.84M | -$75.31M | -$39.42M |
| EBITDA Margin | -38.1% | -52.8% | -76.8% | -136.8% | -96.2% | -78.5% | -26.7% | -83.7% | -151.1% | -156.1% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $378.2M | $525.54M | $1.13B | $141.65M | $492.2M | $832.98M | $143.23M | $140.54M | $72.28M | $33.59M |
| Short-Term Investments | $823.39M | $314.44M | $35.1M | $869.58M | $440.55M | $961.9M | $379.57M | $278.42M | $149.04M | $61.66M |
| Cash and Short-Term Investments | $1.2B | $839.98M | $1.17B | $1.01B | $932.75M | $1.79B | $522.8M | $418.96M | $221.32M | $95.26M |
| Accounts Receivable | $137.85M | $110.25M | $88.78M | $97.26M | $97.65M | $53.3M | $47.99M | $35.69M | $12.79M | $3.5M |
| Inventory | $85.88M | $71.08M | $61.95M | $51.6M | $30.67M | $22.72M | $15.18M | $9.14M | $7.29M | $2.77M |
| Other Current Assets | $40.72M | $33.8M | $27.74M | $31.51M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $1.47B | $1.06B | $1.35B | $1.19B | $1.11B | $1.89B | $597.36M | $468.99M | $242.94M | $103.09M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $304.76M | $279.08M | $302.71M | $341.92M | $313.9M | $100.13M | $72.81M | $31M | $16.04M | $12.63M |
| Goodwill | $77.26M | $3.29M | $3.29M | $3.29M | $3.29M | $3.29M | $3.29M | $0 | $0 | $0 |
| Intangible Assets | $25.92M | $6.76M | $8.98M | $11.73M | $14.21M | $16.16M | $15.41M | $7.8M | $8.74M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $698.03M | $246.6M | $268.78M | $77.56M | $73.25M | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $139.67M | $141.37M | $124.33M | $61.45M | $60.94M | $17.25M | $4.88M | $2.05M | $1.97M | $840K |
| Total Long-Term Assets | $547.61M | $430.5M | $439.31M | $418.39M | $1.09B | $383.42M | $365.18M | $118.41M | $100M | $13.47M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.01B | $1.49B | $1.79B | $1.61B | $2.2B | $2.27B | $962.53M | $587.4M | $342.94M | $116.56M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $54.44M | $38.55M | $51.74M | $68.91M | $38.52M | $7.34M | $16.2M | $10.64M | $5M | $3.16M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $4.22M | $4.63M | $3.05M | $1.47M | $905K | $345K |
| Current Unearned Revenue | $50.75M | $35.47M | $17.96M | $17.4M | $11.33M | $8.55M | $12.28M | $16.14M | $3.11M | $1.9M |
| Other Current Liabilities | $119.65M | $83.22M | $72.74M | $55.79M | $120.5M | $28.28M | $18.56M | $12.99M | $4.91M | $7.3M |
| Total Current Liabilities | $302.73M | $225.58M | $205.92M | $193.22M | $194.69M | $66.81M | $72.73M | $46.94M | $19.63M | $14.28M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $1.5B | $1.14B | $1.14B | $1.14B | $1.13B | $806.29M | $0 | $0 | $0 | $16.48M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $127.77M | $92.83M | $96.01M | $9.18M | $3.93M | $1.52M | $8.55M | $15.51M | $14.24M | $5.68M |
| Total Long-Term Liabilities | $1.81B | $1.4B | $1.42B | $1.36B | $1.36B | $849.38M | $41.81M | $15.51M | $14.71M | $22.59M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.11B | $1.63B | $1.63B | $1.55B | $1.56B | $916.19M | $114.54M | $62.45M | $34.33M | $36.87M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $499.97M | $180M |
| Common Stock | $1K | $1K | $1K | $1K | $1K | $1K | $1K | $1K | $0 | $0 |
| Retained Earnings | -$2.99B | -$2.58B | -$2.14B | -$1.66B | -$1.01B | -$606.59M | -$352.81M | -$280.8M | -$195.74M | -$107.63M |
| Comprehensive Income & Other | -$4.85M | -$5.2M | -$3.67M | -$19.52M | -$4.76M | $2.7M | $1.11M | -$83K | -$532K | -$86K |
| Other Stockholders' Equity | $2.9B | $2.44B | $2.3B | $1.72B | $1.65B | $1.91B | $1.15B | $763.95M | $504.34M | $187.32M |
| Total Equity | -$99.31M | -$139.65M | $158.68M | $60.18M | $645M | $1.3B | $798.39M | $483.15M | $308.61M | $79.7M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $57.1M | $49.6M | $41.8M | $0 | $0 |
| Total Liabilities and Equity | $2.01B | $1.49B | $1.79B | $1.61B | $2.2B | $2.21B | $912.93M | $545.6M | $342.94M | $116.56M |
| Supplementary Data | ||||||||||
| Total Debt | $1.71B | $1.34B | $1.35B | $1.37B | $1.37B | $854.49M | $40.4M | $0 | $659K | $17.04M |
| Net Debt | $1.33B | $810.51M | $220.23M | $1.23B | $881.53M | $21.51M | -$102.83M | -$140.54M | -$71.62M | -$16.55M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$416.28M | -$436.37M | -$479.45M | -$654.59M | -$384.77M | -$246.28M | -$67.85M | -$84.26M | -$83.22M | -$46.14M |
| Depreciation & Amortization | $39.74M | $42.39M | $42.88M | $35.96M | $22.27M | $16.07M | $11.41M | $7.14M | $5.21M | $3.69M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | -$1.6M | $0 | $0 | $0 |
| Stock-Based Compensation | $166.22M | $140.41M | $90.76M | $94.69M | $151.45M | $144.11M | $16.95M | $6.85M | $3.67M | $1.97M |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | -$28.18M | -$21.39M | $8.38M | $375K | -$44.35M | -$5.46M | -$7.39M | -$22.9M | -$9.29M | -$2.79M |
| Inventory | -$14.79M | -$9.13M | -$10.35M | -$20.93M | -$7.96M | -$7.54M | -$6.04M | -$1.85M | -$4.52M | -$351K |
| Accounts Payable | $0 | $0 | $0 | $60.33M | $8.64M | -$7.86M | $4.34M | $5.05M | $1.25M | $2.15M |
| Other Working Capital | $28.54M | -$30.34M | $55.81M | $21.79M | $3.2M | -$26.81M | $790K | $18.58M | $7.57M | $3.45M |
| Total Working Capital Change | -$14.43M | -$60.86M | $53.84M | $61.56M | -$40.47M | -$47.66M | -$8.3M | -$1.13M | -$4.99M | $2.45M |
| Other Non-Cash Items | $39.99M | $74.58M | -$33.01M | $152.91M | $42.5M | $29.84M | $2.25M | -$782K | $7.1M | $1.31M |
| Net Cash from Operating | -$184.76M | -$239.86M | -$324.98M | -$309.46M | -$209.02M | -$103.93M | -$47.13M | -$72.19M | -$72.23M | -$36.71M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$48.31M | -$35.09M | -$20.49M | -$77.46M | -$75.03M | -$36.17M | -$18.72M | -$20.2M | -$6.68M | -$1.77M |
| Acquisitions | -$58.99M | $0 | $0 | $0 | $0 | $0 | -$7.33M | $0 | $0 | $0 |
| Purchases of Investments | -$827.23M | -$314.82M | -$635.5M | -$327.72M | -$940.23M | -$1.13B | -$614.29M | -$287.45M | -$236.84M | -$341.42M |
| Sales of Investments | $307.32M | $88.6M | $1.5B | $555M | $952.11M | $562.55M | $325.33M | $154.63M | $75.4M | $369.38M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | -$17.89M | -$2.57M | $0 | -$2.3M | $0 |
| Net Cash from Investing | -$627.2M | -$261.31M | $840.25M | $149.82M | -$63.16M | -$617.09M | -$317.57M | -$153.03M | -$170.42M | $26.2M |
| Financing Activities | ||||||||||
| Debt Repaid | -$402.5M | - | - | $71K | $146K | -$1.13B | $438K | $443K | $26.09M | $375K |
| Common Stock Issuance | $377.81M | $14.84M | $493.12M | $0 | $0 | $355.73M | $350.43M | $254.01M | $0 | $0 |
| Common Stock Repurchases | -$45.01M | $0 | $0 | $0 | $0 | $0 | $0 | -$172K | -$7.22M | -$100K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$64.17M | -$15.83M | -$15.74M | -$189.02M | -$66.68M | -$78M | $17.31M | $39.77M | $765K | $266K |
| Net Cash from Financing | $671.13M | -$996K | $477.38M | -$189.09M | -$66.82M | $1.41B | $367.3M | $293.16M | $281.66M | $39.84M |
| Forex Effect | $491K | -$1.77M | -$911K | -$1.6M | -$1.69M | $455K | $84K | $0 | $0 | $0 |
| Net Change in Cash | -$140.34M | -$503.93M | $991.74M | -$350.34M | -$340.69M | $689.75M | $2.68M | $67.95M | $39.01M | $29.33M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$184.76M | -$239.86M | -$324.98M | -$309.46M | -$209.02M | -$103.93M | -$47.13M | -$72.19M | -$72.23M | -$36.71M |
| Capital Expenditure | -$48.31M | -$35.09M | -$20.49M | -$77.46M | -$75.03M | -$54.06M | -$21.29M | -$20.2M | -$8.98M | -$1.77M |
| Free Cash Flow | -$233.07M | -$274.94M | -$345.46M | -$386.92M | -$284.05M | -$157.99M | -$68.42M | -$92.39M | -$81.22M | -$38.48M |
| Cash at Beginning | $629.75M | $1.13B | $141.95M | $492.29M | $832.98M | $143.23M | $140.54M | $72.6M | $33.59M | $4.26M |
| Cash at End | $489.42M | $629.75M | $1.13B | $141.95M | $492.29M | $832.98M | $143.23M | $140.54M | $72.6M | $33.59M |